National Maternity Hospital, Ireland Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT03674606
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

National Maternity Hospital, Ireland

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

Atosiban (tractocile) (1 trial)

Drugs in Phase 3 Trials (2)

dopamine (intropin) (1 trial)

glucose monohydrate (1 trial)

Drugs in Other Trials (1)

autologous platelets (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eclampsia (Phase 4)

Fetal Growth Retardation (Phase 4)

Hemorrhage (Phase 3)

Hypotension (Phase 3)

Placenta Diseases (Phase 4)

Pre-Eclampsia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5